Literature DB >> 16960007

Humanization of yeast to produce complex terminally sialylated glycoproteins.

Stephen R Hamilton1, Robert C Davidson, Natarajan Sethuraman, Juergen H Nett, Youwei Jiang, Sandra Rios, Piotr Bobrowicz, Terrance A Stadheim, Huijuan Li, Byung-Kwon Choi, Daniel Hopkins, Harry Wischnewski, Jessica Roser, Teresa Mitchell, Rendall R Strawbridge, Jack Hoopes, Stefan Wildt, Tillman U Gerngross.   

Abstract

Yeast is a widely used recombinant protein expression system. We expanded its utility by engineering the yeast Pichia pastoris to secrete human glycoproteins with fully complex terminally sialylated N-glycans. After the knockout of four genes to eliminate yeast-specific glycosylation, we introduced 14 heterologous genes, allowing us to replicate the sequential steps of human glycosylation. The reported cell lines produce complex glycoproteins with greater than 90% terminal sialylation. Finally, to demonstrate the utility of these yeast strains, functional recombinant erythropoietin was produced.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960007     DOI: 10.1126/science.1130256

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  145 in total

Review 1.  Emerging technologies for making glycan-defined glycoproteins.

Authors:  Lai-Xi Wang; Joseph V Lomino
Journal:  ACS Chem Biol       Date:  2011-12-14       Impact factor: 5.100

2.  A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway.

Authors:  Jared J Aumiller; Hideaki Mabashi-Asazuma; Alexander Hillar; Xianzong Shi; Donald L Jarvis
Journal:  Glycobiology       Date:  2011-10-31       Impact factor: 4.313

3.  Biopharmaceutical benchmarks 2010.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

4.  Essential role of YlMPO1, a novel Yarrowia lipolytica homologue of Saccharomyces cerevisiae MNN4, in mannosylphosphorylation of N- and O-linked glycans.

Authors:  Jeong-Nam Park; Yunkyoung Song; Seon Ah Cheon; Ohsuk Kwon; Doo-Byoung Oh; Yoshifumi Jigami; Jeong-Yoon Kim; Hyun Ah Kang
Journal:  Appl Environ Microbiol       Date:  2010-12-23       Impact factor: 4.792

5.  Engineering of Yeast Glycoprotein Expression.

Authors:  Charlot De Wachter; Linde Van Landuyt; Nico Callewaert
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

6.  Remodeling of the glycosylation pathway in the methylotrophic yeast Hansenula polymorpha to produce human hybrid-type N-glycans.

Authors:  Seon Ah Cheon; Hyunah Kim; Doo-Byoung Oh; Ohsuk Kwon; Hyun Ah Kang
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

7.  Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines.

Authors:  Michael Luong; Jennifer S Lam; Jianmin Chen; Stuart M Levitz
Journal:  Vaccine       Date:  2007-03-30       Impact factor: 3.641

Review 8.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

Review 9.  Emerging methods for the production of homogeneous human glycoproteins.

Authors:  Jamie R Rich; Stephen G Withers
Journal:  Nat Chem Biol       Date:  2009-04       Impact factor: 15.040

10.  Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk.

Authors:  Geun-Cheol Gil; William H Velander; Kevin E Van Cott
Journal:  Glycobiology       Date:  2008-05-02       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.